Login Register Cart 0
Generic placeholder image

Current Psychiatry Research and Reviews

Editor-in-Chief

ISSN (Print): 2666-0822
ISSN (Online): 2666-0830

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Research Article

The Effect of Some Symptoms and Features During the Infection Period on the Level of Anxiety and Depression of Adults after Recovery from COVID-19

Author(s): Mehmet Tahir Huyut* and İdris Kocaturk

Volume 18, Issue 2, 2022

Published on: 13 May, 2022

Page: [151 - 163] Pages: 13

DOI: 10.2174/2666082218666220325105504

Price: $65

Abstract

Background: Considering the previous evidence regarding SARS/MERS outbreaks, ıt is expected that emergent psychiatric conditions such as mood disorders, anxiety, and depression disorders may occur in survivors of COVID-19.

Objectives: In this study, the effects of clinical/neurological symptoms and sociodemographic characteristics of COVID-19 patients during the infection period on the level of anxiety/depression after recovery were investigated.

Methods: Firstly, the socio-demographic characteristics of the participants and their clinical/ neurological symptoms during the infection period were determined. In addition, the Beck anxiety/depression scale was administered to the participants upon discharge. Then, the odds ratio of the variables was calculated by applying the Poisson regression method to determine the predictors affecting the level of anxiety/depression.

Results: In this study, the clinical/neurological symptoms and the sociodemographic characteristics affecting the level of anxiety/depression were found to be associated with adults (mean age 45-years). The number of days of hospitalization was the only clinical feature that increased both anxiety and depression levels. In addition, post-discharge sleep disorder, headache, and alcohol use were found to be predictors of increased anxiety levels. In addition, smoking, the presence of a person with COVID-19 infection in the immediate vicinity, traveling in the last month before the illness, fever, and loss of smell during the infection period was found to increase the level of depression. Moreover, asthma was the only significant comorbidity that increased the anxiety level, while diabetes was the only comorbidity that increased the depression level.

Conclusion: It is expected that this study will support social-psychological intervention and have some effects on reducing depressive/anxiety symptoms, which can vary widely in adults during stressful events.

Keywords: SARS-Cov-2, COVID-19, depression, anxiety disorders, poisson regression models, comorbidity.

« Previous Next »
Graphical Abstract

[1]
Mertoğlu C, Huyut MT, Ölmez H, et al., COVID-19 is more dangerous for older people and its severity is increasing: a case-control study, Med Gas Res 12 (2) (2022) 51-54.
[http://dx.doi.org/10.4103/2045-9912.325992]
[2]
Huyut MT. Üstündağ H. Prediction of diagnosis and prognosis of COVID-19 disease by blood gas parameters using decision trees machine learning model: a retrospective observational study. Med Gas Res 2022; 12(2): 60-6.
[3]
Huyut MT, Huyut Z. Forecasting of Oxidant/Antioxidant levels of COVID-19 patients by using Expert models with biomarkers used in the Diagnosis/Prognosis of COVID-19. Int Immunopharmacol 2021; 100: 108127.
[http://dx.doi.org/10.1016/j.intimp.2021.108127] [PMID: 34536746]
[4]
Pfefferbaum B, North CS. Mental health and the Covid-19 pandemic. N Engl J Med 2020; 383(6): 510-2.
[http://dx.doi.org/10.1056/NEJMp2008017]
[5]
Kang L, Li Y, Hu S, et al. The mental health of medical workers in Wuhan, China dealing with the 2019 novel corona-virus. Lancet Psychiatry 2020; 7(3): e14.
[http://dx.doi.org/10.1016/S2215-0366(20)30047-X] [PMID: 32035030]
[6]
Huyut MT, Soygüder S. Coronavirus 19 Infection and the Levels of Anxiety and Depression post Covid. East J Med 2022; 27(1): 1-10.
[7]
Liu D, Baumeister RF, Veilleux JC, et al. Risk factors associated with mental illness in hospital discharged patients in-fected with COVID-19 in Wuhan, China. Psychiatry Res 2020; 292: 113297.
[http://dx.doi.org/10.1016/j.psychres.2020.113297] [PMID: 32707218]
[8]
Balachandar V, Mahalaxmi I, Subramaniam M, et al. Follow-up studies in COVID-19 recovered patients - is it manda-tory? Sci Total Environ 2020; 729: 139021.
[http://dx.doi.org/10.1016/j.scitotenv.2020.139021] [PMID: 32360909]
[9]
Poyraz BÇ, Poyraz CA, Olgun Y, et al. Psychiatric morbidity and protracted symptoms after COVID-19. Psychiatry Res 2021; 295: 113604.
[http://dx.doi.org/10.1016/j.psychres.2020.113604] [PMID: 33296818]
[10]
Rogers JP, Chesney E, Oliver D, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: A systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry 2020; 7(7): 611-27.
[http://dx.doi.org/10.1016/S2215-0366(20)30203-0] [PMID: 32437679]
[11]
Tomasoni D, Bai F, Castoldi R, et al. Anxiety and depression symptoms after virological clearance of COVID-19: A cross-sectional study in Milan, Italy. J Med Virol 2021; 93(2): 1175-9.
[http://dx.doi.org/10.1002/jmv.26459] [PMID: 32841387]
[12]
Xiang YT, Yang Y, Li W, et al. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. Lancet Psychiatry 2020; 7(3): 228-9.
[http://dx.doi.org/10.1016/S2215-0366(20)30046-8] [PMID: 32032543]
[13]
Vindegaard N, Benros ME. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence. Brain Behav Immun 2020; 89: 531-42.
[http://dx.doi.org/10.1016/j.bbi.2020.05.048] [PMID: 32485289]
[14]
Cameron AC, Trivedi P. Econometric models based on count data: Comparisons and applications of some estimators. J App Econometrics 1986; 1>: 29-53. Available from: https://ideas.repec.org/s/jae/japmet.html
[15]
Frome EL. The analysis of rates using poisson regression models. Biometrics 1983; 39(3): 665-74.
[http://dx.doi.org/10.2307/2531094] [PMID: 6652201]
[16]
Huyut MT, İlkbahar F. The effectiveness of blood routine parameters and some biomarkers as a potential diagnostic tool in the diagnosis and prognosis of Covid-19 disease. Int Immunopharmacol 2021; 98: 107838.
[http://dx.doi.org/10.1016/j.intimp.2021.107838] [PMID: 34303274]
[17]
Mertoglu C, Huyut MT, Arslan Y, Ceylan Y, Coban TA. How do routine laboratory tests change in coronavirus disease 2019? Scand J Clin Lab Invest 2021; 81(1): 24-33.
[http://dx.doi.org/10.1080/00365513.2020.1855470] [PMID: 33342313]
[18]
Huyut MT, Huyut Z. İlkbahar F, Mertoğlu C. What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality? Int Immunopharmacol 2022; 105: 108542.
[19]
Sarıçam H. The psychometric properties of Turkish version of depression anxiety stress Scale-21 (DASS-21) in community and clinical samples. Journal of Cognitive Behavioral Psychotherapy and Research 2018; 7: 19-30.
[http://dx.doi.org/10.5455/JCBPR.274847]
[20]
Mukhtar S. Psychological health during the coronavirus disease 2019 pandemic outbreak. Int J Soc Psychiatry 2020; 66(5): 512-6.
[http://dx.doi.org/10.1177/0020764020925835] [PMID: 32434402]
[21]
Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan. JAMA Neurol 2020; 77(6): 683-90.
[http://dx.doi.org/10.1001/jamaneurol.2020.1127] [PMID: 32275288]
[22]
Xiong W, Mu J, Guo J, et al. New onset neurologic events in people with COVID-19 in 3 regions in China. Neurology 2020; 95(11): e1479-87.
[http://dx.doi.org/10.1212/WNL.0000000000010034] [PMID: 32554771]
[23]
Keyhanian K, Umeton RP, Mohit B, Davoudi V, Hajighasemi F, Ghasemi M. SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation. J Neuroimmunol 2020; 350: 577436.
[http://dx.doi.org/10.1016/j.jneuroim.2020.577436] [PMID: 33212316]
[24]
Lee SM, Kang WS, Cho AR, Kim T, Park JK. Psychological impact of the 2015 MERS outbreak on hospital workers and quarantined hemodialysis patients. Compr Psychiatry 2018; 87: 123-7.
[http://dx.doi.org/10.1016/j.comppsych.2018.10.003] [PMID: 30343247]
[25]
Alsubaie S, Hani Temsah M, Al-Eyadhy AA, et al. Middle east respiratory syndrome coronavirus epidemic impact on healthcare workers’ risk perceptions, work and personal lives. J Infect Dev Ctries 2019; 13(10): 920-6.
[http://dx.doi.org/10.3855/jidc.11753] [PMID: 32084023]
[26]
Al-Rabiaah A. Temşah MH, Al-Eyadhy AA, et al. Middle east respiratory syndrome-corona virus (MERS-CoV) associ-ated stress among medical students at a university teaching hospital in Saudi Arabia. J Infect Public Health 2020; 13(5): 687-91.
[http://dx.doi.org/10.1016/j.jiph.2020.01.005] [PMID: 32001194]
[27]
Srivatsa S, Stewart KA. How should clinicians integrate mental health into epidemic responses? AMA J Ethics 2020; 22(1): E10-5.
[http://dx.doi.org/10.1001/amajethics.2020.10] [PMID: 31958385]
[28]
Rodríguez BO, Sánchez TL. The psychosocial impact of COVID-19 on health care workers. NT BRAZ J UROL 2020; 46(1): 195-200.
[29]
Liu X, Kakade M, Fuller CJ, et al. Depression after exposure to stressful events: Lessons learned from the severe acute respiratory syndrome epidemic. Compr Psychiatry 2012; 53(1): 15-23.
[http://dx.doi.org/10.1016/j.comppsych.2011.02.003] [PMID: 21489421]
[30]
Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L. Features of 20 133 UK patients in hospital with COVID‐19 using the ISARIC WHO clinical characterisation protocol: Prospective observational cohort study. BMJ 2020. 369(m1985)
[http://dx.doi.org/10.1136/bmj.m1985]
[31]
Cheng SKW, Wong CW, Tsang J, Wong KC. Psychological distress and negative appraisals in survivors of severe acute respiratory syndrome (SARS). Psychol Med 2004; 34(7): 1187-95.
[http://dx.doi.org/10.1017/S0033291704002272] [PMID: 15697045]
[32]
Lam MHB, Wing YK, Yu MWM, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: Long-term follow-up. Arch Intern Med 2009; 169(22): 2142-7.
[http://dx.doi.org/10.1001/archinternmed.2009.384] [PMID: 20008700]
[33]
Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun 2020; 87: 18-22.
[http://dx.doi.org/10.1016/j.bbi.2020.03.031] [PMID: 32240762]
[34]
Holmes EA, O’Connor RC, Perry VH, et al. Multidisciplinary research priorities for the COVID-19 pandemic: A call for action for mental health science. Lancet Psychiatry 2020; 7(6): 547-60.
[http://dx.doi.org/10.1016/S2215-0366(20)30168-1] [PMID: 32304649]
[35]
McNally RJ, Robinaugh DJ, Wu GWY, Wang L, Deserno MK, Borsboom D. Mental disorders as causal systems: A net-work approach to posttraumatic stress disorder. Clin Psychol Sci 2014; 3(6): 836-49.
[http://dx.doi.org/10.1177/2167702614553230]
[36]
Mak IWC, Chu CM, Pan PC, Yiu MGC, Chan VL. Long-term psychiatric morbidities among SARS survivors. Gen Hosp Psychiatry 2009; 31(4): 318-26.
[http://dx.doi.org/10.1016/j.genhosppsych.2009.03.001] [PMID: 19555791]

Rights & Permissions Print Cite
Article Metrics
11
1
© 2024 Bentham Science Publishers | Privacy Policy